Blog

News March 27, 2021

Amplicore Closes $4M Seed Funding

– Amplicore from Cincinnati develops minimally invasive therapeutic solutions for musculoskeletal diseases. – The company closed its $4m seed round of funding. – The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital. – The new investment will be used to complete the preclinical development of the company’s two leading products, AM3101 and AM1101, and position itself for the next round of financing.